Cargando…

Lipid and Bile Acid Dysmetabolism in Crohn's Disease

Crohn's disease is one of the systemic autoimmune diseases. It commonly affects the small intestine and colon but may involve any portion of the gastrointestinal tract from the mouth to the anus. The most affected area by Crohn's disease is the distal part of the small intestine, in which...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchiyama, Koji, Kishi, Hisashi, Komatsu, Wataru, Nagao, Masanori, Ohhira, Shuji, Kobashi, Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191959/
https://www.ncbi.nlm.nih.gov/pubmed/30402511
http://dx.doi.org/10.1155/2018/7270486
_version_ 1783363816740880384
author Uchiyama, Koji
Kishi, Hisashi
Komatsu, Wataru
Nagao, Masanori
Ohhira, Shuji
Kobashi, Gen
author_facet Uchiyama, Koji
Kishi, Hisashi
Komatsu, Wataru
Nagao, Masanori
Ohhira, Shuji
Kobashi, Gen
author_sort Uchiyama, Koji
collection PubMed
description Crohn's disease is one of the systemic autoimmune diseases. It commonly affects the small intestine and colon but may involve any portion of the gastrointestinal tract from the mouth to the anus. The most affected area by Crohn's disease is the distal part of the small intestine, in which the bile acid molecules are most efficiently reabsorbed. Bile acids form mixed micelles together with fatty acids, which function as a transport vehicle to deliver fatty acids to the apical membrane of enterocytes for absorption. Therefore, if the terminal ileum is impaired, bile acid malabsorption may occur, which may cause congenital diarrhoea in Crohn's disease. Similarly, the impairment of the terminal ileum also induces fatty acid malabsorption, which may influence the role of fatty acids in Crohn's disease. In contrast, a recent study reported that multidrug resistance protein 1 (MDR1) regulated effector T-cell function in the ileum from bile acid-driven oxidative stress and MDR1 loss of function in a subset of patients with Crohn's disease. However, the role of consumption of fatty acids in Crohn's disease remains to be fully elucidated. This review is aimed at providing an overview of some recent developments in research of Crohn's disease from comprehensive perspective with a focus on the connection between disease location and behaviour, lipid diets, and bile acid malabsorption.
format Online
Article
Text
id pubmed-6191959
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-61919592018-11-06 Lipid and Bile Acid Dysmetabolism in Crohn's Disease Uchiyama, Koji Kishi, Hisashi Komatsu, Wataru Nagao, Masanori Ohhira, Shuji Kobashi, Gen J Immunol Res Review Article Crohn's disease is one of the systemic autoimmune diseases. It commonly affects the small intestine and colon but may involve any portion of the gastrointestinal tract from the mouth to the anus. The most affected area by Crohn's disease is the distal part of the small intestine, in which the bile acid molecules are most efficiently reabsorbed. Bile acids form mixed micelles together with fatty acids, which function as a transport vehicle to deliver fatty acids to the apical membrane of enterocytes for absorption. Therefore, if the terminal ileum is impaired, bile acid malabsorption may occur, which may cause congenital diarrhoea in Crohn's disease. Similarly, the impairment of the terminal ileum also induces fatty acid malabsorption, which may influence the role of fatty acids in Crohn's disease. In contrast, a recent study reported that multidrug resistance protein 1 (MDR1) regulated effector T-cell function in the ileum from bile acid-driven oxidative stress and MDR1 loss of function in a subset of patients with Crohn's disease. However, the role of consumption of fatty acids in Crohn's disease remains to be fully elucidated. This review is aimed at providing an overview of some recent developments in research of Crohn's disease from comprehensive perspective with a focus on the connection between disease location and behaviour, lipid diets, and bile acid malabsorption. Hindawi 2018-10-01 /pmc/articles/PMC6191959/ /pubmed/30402511 http://dx.doi.org/10.1155/2018/7270486 Text en Copyright © 2018 Koji Uchiyama et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Uchiyama, Koji
Kishi, Hisashi
Komatsu, Wataru
Nagao, Masanori
Ohhira, Shuji
Kobashi, Gen
Lipid and Bile Acid Dysmetabolism in Crohn's Disease
title Lipid and Bile Acid Dysmetabolism in Crohn's Disease
title_full Lipid and Bile Acid Dysmetabolism in Crohn's Disease
title_fullStr Lipid and Bile Acid Dysmetabolism in Crohn's Disease
title_full_unstemmed Lipid and Bile Acid Dysmetabolism in Crohn's Disease
title_short Lipid and Bile Acid Dysmetabolism in Crohn's Disease
title_sort lipid and bile acid dysmetabolism in crohn's disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191959/
https://www.ncbi.nlm.nih.gov/pubmed/30402511
http://dx.doi.org/10.1155/2018/7270486
work_keys_str_mv AT uchiyamakoji lipidandbileaciddysmetabolismincrohnsdisease
AT kishihisashi lipidandbileaciddysmetabolismincrohnsdisease
AT komatsuwataru lipidandbileaciddysmetabolismincrohnsdisease
AT nagaomasanori lipidandbileaciddysmetabolismincrohnsdisease
AT ohhirashuji lipidandbileaciddysmetabolismincrohnsdisease
AT kobashigen lipidandbileaciddysmetabolismincrohnsdisease